Quinine.
Quinine is the bitter alkaloid from cinchona bark. In drinks and bitters formulas it works as a flavour compound at tightly limited levels rather than as an active amount.
- Category
- Herb
What Quinine is, and what it does.
- Does it work
- It suits people who want that classic dry bitter note in a drink or a bitters preparation. Above flavour level it sits with a prescriber rather than on a shelf.
- How much to take
- No daily supplement amount is on record, and none should be inferred. In drinks it is used at flavour level only, and anything beyond that is a prescribing decision.
- Time to feel it
- The bitterness registers within a second of it touching your tongue. Beyond taste, nobody has measured a supplement-scale timeline for it.
- The first dose
- Day one is the bitter taste, and that part is immediate. At flavour concentrations no further day-one effect has been measured in people.
- With regular use
- Nobody has measured what weeks of flavour-level quinine do. At prescription amounts the long view belongs to the clinician who wrote it.
- How well tolerated
- Quinine is linked to immune-mediated blood reactions, which is why several regulators restrict it off prescription. It also inhibits CYP2D6. Ask your doctor before any real amount.
- How it feels
- Intensely bitter, drying, with a faint metallic edge at the back of the palate. At flavour level that taste is the whole experience.
- The overlooked benefit
- It is the reference bitterant of sensory science, the yardstick every other bitter compound is measured against on human bitter taste receptors.
The proof, claim by claim.
What these words mean
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Bitter taste receptor activationIn vitro study
- Occasional night-time muscle crampingMeta-analysis
3 more claims
- Skeletal muscle end plate excitabilityAnimal study
- Cardiac potassium channel activityIn vitro study
- CYP2D6 inhibition and the clearance of other substancesNarrative review
Why these belong in the same formula, 5 pairings
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Quinine reduces the excitability of the motor end plate and lengthens the refractory period of muscle fibre, which is the pharmacological reason it was historically taken for night-time muscle cramping. Magnesium acts at the neuromuscular junction by a different route. Taken together the effects point the same direction on paper. Regulators in several countries have restricted quinine for cramping because of blood disorder reports, so this pairing is documented history rather than a current recommendation.
Quinine alters calcium movement in muscle fibre, which is part of how it changes contraction and relaxation timing. The source index flags calcium co-occurrence as antagonistic rather than cooperative. That means the relationship is one to be aware of, not one to build a formula around. The direction and size of any effect at supplement-level intakes has not been characterised.
Quinine and its stereoisomer quinidine block potassium channels and prolong cardiac repolarisation, which is well documented pharmacology and the reason quinidine was used as an antiarrhythmic. The co-occurrence index flags potassium as antagonistic. Anyone taking potassium alongside a quinine-containing product should regard the combination as a cardiac electrophysiology question for a clinician. This is a caution, not a synergy.
Cinchona bark preparations contain condensed tannins alongside the alkaloids, and polyphenol binding of non-haem iron in the intestinal lumen is settled nutrition chemistry. A bitter bark tonic taken with a meal will reduce iron uptake from that meal. Purified quinine salts do not carry this liability because the tannins are removed. The distinction between bark and isolated alkaloid matters here.
Quinine is a reference agonist in bitter taste receptor research and activates TAS2R subtypes at low concentration. Bitter receptor stimulation is the classical mechanism behind aperitif bitters and gastric secretion. Enzyme preparations act further down the same digestive sequence by supplying hydrolytic capacity directly. The pairing is mechanistically coherent, and quinine at food-flavouring levels is the only intake relevant to it.
Nothing specific on file for Quinine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Quinine actually does.
Quinine comes from cinchona bark, and its mirror-image relative quinidine differs by only a small structural detail yet acts very differently on the heart.
3 more mechanisms
Quinine is used as the reference bitter compound for measuring taste receptor activation, which is also why it flavors tonic water, though only at tightly limited amounts.
Quinine and its relative quinidine can interfere with the heart's electrical rhythm, which is why quinidine has been used as a prescription heart-rhythm medicine and why this effect needs a prescriber's oversight, not self-directed use.
Quinine dampens the excitability of the nerve-muscle junction, which is the proposed reason it was historically used for nighttime muscle cramps.
Getting Quinine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
3 more forms
The essence, in one line each.
- A cinchona-based liquid formulation showed antifungal activity in the test system, reported as tryptophan starvation and mitochondrial disruption in the target organism.In vitro study. Das S et al., 2025 (Scientific Reports). PMID 41203652 ↗
Chosen from the 1 we read for Quinine.
The studies, linked.
12 sources behind our Quinine verdict, every one linked to PubMed, the journal or ClinicalTrials.gov.
- Clinical trialParenteral Artesunate Compared to Quinine as a Cause of Late Post-treatment Anaemia in African Children With Hyperparasitaemic P. Falciparum MalariaClinicalTrials.gov ↗Phase 4, 217 participants, Completed
11 more linked trials
- Clinical trialImpact of Different Treatment Modalities on Immunity Against COVID-19ClinicalTrials.gov ↗Phase 2, 150 participants, Completed
- Clinical trialBio-availability of Rectal Artesunate in Children With Severe Falciparum MalariaClinicalTrials.gov ↗Phase 2, 82 participants, Completed
- Clinical trialSafety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease (ROCK-PD)ClinicalTrials.gov ↗Phase 2, 81 participants, Completed
- Clinical trialA One-Directional, Open-Label Drug Interaction Study to Investigate the Effects of Multiple-Dose Ciprofloxacin HCl on the Single-Dose Pharmacokinetics of Quinine in Healthy VolunteersClinicalTrials.gov ↗Phase 1, 24 participants, Completed
- Clinical trialA Pharmacokinetic Drug-Drug Interaction Study to Evaluate the Effect of Steady-State Quinine Sulfate on the Pharmacokinetics of Single-Dose Theophylline in Healthy Adult MalesClinicalTrials.gov ↗Phase 1, 24 participants, Completed
- Clinical trialAn Open-Label Drug-Drug Interaction Study to Investigate the Effects of Steady State Quinine on the Single-Dose Pharmacokinetics of Rosiglitazone Maleate in Healthy VolunteersClinicalTrials.gov ↗Phase 1, 23 participants, Completed
- Clinical trialEffects of Intragastric Quinine, Alone or Combined With L-isoleucine, on Postprandial Glycaemic ControlClinicalTrials.gov ↗15 participants, Completed
- Clinical trialPharmacodynamic and Pharmacokinetic Interactions Between Intravenous Cocaine and Acetazolamide or QuinineClinicalTrials.gov ↗Phase 1, 14 participants, Completed
- ClinicalTrials.gov ↗
- Clinical trialInfluence of Probenecid and Quinine on the Pharmacokinetics of AzidothymidineClinicalTrials.gov ↗12 participants, Completed
- Clinical trialTaste Physiology in Obese Volunteers Before and After Bariatric SurgeryClinicalTrials.gov ↗16 participants, Recruiting
From clinical trials and PubMed, ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 33,081 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Quinine is, not how risky it is. A report is not proof Quinine caused anything. It is a signal of what to watch for, nothing more.
3 more reported effects
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.